All EHA CAR-T Abstracts
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
ciltacabtagene autoleucel
CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel, A B-Cell Maturation Antigen Directed Chimeric Antigen Receptor T cell Therapy, in Relapsed/Refractory Multiple Myeloma.
Preliminary results indicate that anti-BCMA CAR-T cell therapy, ciltacabtagene autleucel (cilta-cel), resulted in early, deep and durable responses in heavily pre-treated patients with MM. ORR was , sCR . Durability […]